Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
Mechanisms of PPM1D in Medulloblastoma Tumorigenesis and Invasion |
Emory University / Robert Craig Castellino, MD |
Bridge Grants |
2012 |
Georgia |
Childhood Leukemia in Kenya Identified Through Malaria Slide Review |
Indiana University / Terry Vik |
Epidemiology Grants |
2012 |
Indiana |
Discovery of New Targets and Pathways for T-ALL Therapy |
Dana-Farber Cancer Institute / Thomas Look |
Bridge Grants |
2012 |
Massachusetts |
Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute / Julia Etchin |
Young Investigator Grants |
2012 |
Massachusetts |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma |
Dana-Farber Cancer Institute / Kimberly Stegmaier, MD |
Bridge Grants |
2012 |
Massachusetts |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |